GPR40 (FFAR1) – Combined Gs and Gq signaling in vitro is associated with robust incretin secretagogue action ex vivo and in vivo

OBJECTIVES: GPR40 (FFAR1), a clinically proven anti-diabetes target, is a Gq-coupled receptor for long chain fatty acids (LCFA) stimulating insulin secretion directly and mediating a major part of the dietary triglyceride-induced secretion of the incretins GLP-1 and GIP. In phase-II studies the GPR4...

Descripción completa

Detalles Bibliográficos
Autores principales: Hauge, Maria, Vestmar, Marie A., Husted, Anna S., Ekberg, Jeppe P., Wright, Michael J., Di Salvo, Jerry, Weinglass, Adam B., Engelstoft, Maja S., Madsen, Andreas N., Lückmann, Michael, Miller, Michael W., Trujillo, Maria E., Frimurer, Thomas M., Holst, Birgitte, Howard, Andrew D., Schwartz, Thue W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314522/
https://www.ncbi.nlm.nih.gov/pubmed/25685685
http://dx.doi.org/10.1016/j.molmet.2014.10.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314522/
https://www.ncbi.nlm.nih.gov/pubmed/25685685
http://dx.doi.org/10.1016/j.molmet.2014.10.002

Ejemplares similares